secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2023-08-18T23:59:59+00:00
Accession:  0001193125-23-216056
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD appoints Joseph Ziegler as Principal Financial Officer after resignation of Michael Donegan
--------------------------------------------------------------------------------

- Entered Master Services Agreement with JZ Advisory Group for $10,000/month plus 7,500 restricted stock units for Joseph Ziegler as Principal Financial Officer
- Michael Donegan resigned as Principal Financial and Accounting Officer effective August 17, 2023
- Joseph Ziegler, founder of JZ Advisory Group, succeeded Donegan; previously CFO at DAS Health and Encompass Onsite
- Agreement has a three-year term with automatic renewal unless either party provides 30-day non-extension notice

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312523216056/0001193125-23-216056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312523216056/d462055d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-216056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer